688310 迈得医疗
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-1.9987.768-2.34511.6558.465
总资产报酬率 ROA (%)-1.4475.801-1.8149.1256.991
投入资产回报率 ROIC (%)-1.6076.498-2.05410.5607.877

边际利润分析
销售毛利率 (%)36.64644.66643.85251.30850.457
营业利润率 (%)-20.11113.280-9.96826.64822.665
息税前利润/营业总收入 (%)-19.13113.582-11.57624.96119.830
净利润/营业总收入 (%)-21.2269.961-10.92022.82420.085

收益指标分析
经营活动净收益/利润总额(%)126.56753.652149.26975.24680.335
价值变动净收益/利润总额(%)-6.1607.240-7.6652.1383.557
营业外收支净额/利润总额(%)1.1162.5016.279-0.4240.348

偿债能力分析
流动比率 (X)2.5242.9783.7823.7833.293
速动比率 (X)1.7072.2912.9123.0282.689
资产负债率 (%)28.32926.18519.74118.22820.097
带息债务/全部投入资本 (%)19.12515.13013.0738.0906.972
股东权益/带息债务 (%)409.793544.275650.8611,112.1691,309.423
股东权益/负债合计 (%)254.514277.719389.527426.448392.593
利息保障倍数 (X)-15.852-349.79912.311-15.844-6.805

营运能力分析
应收账款周转天数 (天)86.39888.132172.70296.287110.835
存货周转天数 (天)314.117220.375330.327200.373205.543